Franklin Genomic Advancements Etf (HELX) Technical Analysis

$29.79▲1.44%

Market is closed - opens 8 PM, 26 Dec 2024

Insights

Franklin Genomic Advancements Etf is currently in a neutral trading position according to technical analysis indicators.
Based on analysis of the Oscillators technical indicator, the current market trend for Franklin Genomic Advancements Etf stock suggests that it is range bound and no decision can be made based on this information
Based on analysis of the Moving Averages technical indicator, Franklin Genomic Advancements Etf stock is in a downtrend↘️
Based on analysis of the Pivot Points, the current market trend for Franklin Genomic Advancements Etf stock suggests that it is a good time to buy

Analysis Summary

Oscillators

Sell

Neutral

Buy

Moving Averages

Sell

Neutral

Buy

Pivots

Sell

Neutral

Buy

Oscillators

Name	Value	Action
Relative Strength Index	45.43	Neutral
Stochastic	44.05, 30.66	Neutral
Ultimate Oscillator	52.04	Neutral
Stochastic Relative Strength Index	36.1, 20.24	Neutral
Moving Average Convergence Divergence	-0.33, -0.23	Neutral

Moving Averages

Simple Moving Average

Period (Days)	Value	Action
10	29.83	Sell
20	30.35	Sell
50	30.58	Sell

Exponential Moving Average

Period (Days)	Value	Action
10	29.77	Sell
20	30.05	Sell
50	30.6	Sell

Volume Weighted Moving Average

Period (Days)	Value	Action
10	30.0	Neutral
20	30.57	Neutral
50	30.55	Neutral

Double Exponential Moving Average

Period (Days)	Value	Action
10	29.4	Sell
20	29.65	Sell
50	29.77	Sell

Triple Exponential Moving Average

Period (Days)	Value	Action
10	29.27	Sell
20	29.53	Sell
50	29.64	Sell

Pivot

Pivot	Value
Resistance L3	29.71
Resistance L2	29.54
Resistance L1	29.45
Pivot Point	29.28
Support L1	29.2
Support L2	29.03
Support L3	28.94

*Disclaimer: The content present here is for informational purposes only, you should not construe any such information or other material as investment advisory.